Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer

Clinical trial NCT07129018 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07129018
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer (BTC)First-line Therapy

Start date: 2025-11-01
Primary completion: 2027-11-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.